Eli Lilly and Company

LLYCL.SN·Santiago·Healthcare
Compare
1,394,000.000.00 (0.00%)today
At close: Oct 22, 2:53 PM CLST · May be delayed up to 20 min · CLP

Prices may be delayed up to 20 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close1,394,000.00
Open1,290,000.00
Day range1,290,000.001,394,000.00
52-week range766,500.001,290,000.00
Off day high0.00%
Off 52-week high0.00%
Volume2.00
Avg. volume (3M)2.00
Market cap1,241.70T
EPS (TTM)28,183.09
Forward P/E—
P/E ratio (TTM)49.46
Dividend yield0.53% (6,784.31)
Beta (5Y)0.39
Shares outstanding890.75M
Short interest—
Earnings dateOct 29, 2026
Analyst target—
Profit margin31.90%

Against its peers

Compare in full ›
LLYCL.SN BIIB BMY 0QCV.IL 0QYQ.IL CUP.F
Market cap 1,241.70T 37.61B 131.21B 535.73B 215.56B 65.86B
P/E (TTM) 49.5 110.2 14.2 61.3 39.8 24.0
Forward P/E — 15.6 9.6 — — 0.3
Price/book 30,849.6 2.0 5.6 40.9 10.2 5.6
Dividend yield 0.53% — 3.93% 4.05% 3.81% 1.93%
1-year change +45.22% +62.35% +37.66% +33.33% +38.91% −1.48%
Today 0.00% +2.22% +4.02% +4.86% +0.58% +4.33%

The closest companies by business and industry (Drug Manufacturers - General). Prices may be delayed up to 20 min.

Latest news

All LLYCL.SN news ›
Seeking Alpha·Positive

Eli Lilly: Higher Volume, Lower Realized Prices

Pharmaceutical company Eli Lilly and Company (LLY) reported volume growth of 53% last quarter against a 15% decline in realized prices. Revenue rose 39%. Gross margin went up year-over-year, too. That combination is unusual Best Stocks Now…

Trefis·Negative

Is Eli Lilly Stock Increasing Your Market Risk?

Eli Lilly Stock Has Barely Followed The Market No, not over the past year. Between October 31, 2025, and November 3, 2026, the S&P 500 lost 0.606% on the average day it fell, while a $10,000 holding of Lilly stock gained about $15.70. On…

Trefis·

The One Thing To Settle Before Buying Eli Lilly Stock

Eli Lilly (LLY) is selling far more of two drugs, Mounjaro and Zepbound, than it did a year ago. The price the company collects in the U.S., however, is falling. For anyone who owns the stock, the depth of that decline is not settled. This…

Seeking Alpha·Negative

Eli Lilly: Priced For Acceleration, Reporting Deceleration

Eli Lilly delivered strong Q3 results, but underlying growth slowed from 49% to 35% and price erosion deepened. Read more on LLY stock here. - Eli Lilly delivered strong Q3 results, but underlying growth slowed from 49% to 35% and price…

From the 4Search news index, newest first.

In the news

363mentions in 30 days
363with it in the headline
Positivesentiment

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 120 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance